Skip to main content
Top
Published in: Metabolic Brain Disease 2/2013

01-06-2013 | Original Paper

Psychometric tests for diagnosing minimal hepatic encephalopathy

Author: Karin Weissenborn

Published in: Metabolic Brain Disease | Issue 2/2013

Login to get access

Abstract

While it is consensus that minimal hepatic encephalopathy (mHE) has significant impact on a patient’s daily living, and thus should be diagnosed and treated, there is no consensus about the optimal diagnostic tools. At present the most frequently used psychometric methods for diagnosing minimal hepatic encephalopathy are the Inhibitory Control Test and the Psychometric Hepatic Encephalopathy Score PHES. Another frequently used method is Critical Flicker Frequency. The PHES and the Repeatable Battery for the Assessment of Neuropsychological Status have been recommended for diagnosing mHE by a working party commissioned by the International Society for Hepatic Encephalopathy and Nitrogen Metabolism. Recently the Continuous Reaction Time Test, which has been used in the 1980ies, has gained new interest. Today, no data are available that allow to decide which of these methods is the most appropriate. In fact, even basic information such as dependence on age, sex and education or influence of diseases that frequently accompany liver cirrhosis upon test results is missing for most of them. Future studies must address these questions to improve diagnosis of mHE.
Literature
go back to reference Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3–4):253–67PubMedCrossRef Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3–4):253–67PubMedCrossRef
go back to reference Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2):510–518PubMedCrossRef Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2):510–518PubMedCrossRef
go back to reference Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory Control Test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102:754–760PubMedCrossRef Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory Control Test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102:754–760PubMedCrossRef
go back to reference Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroent 16:441–447PubMedCrossRef Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroent 16:441–447PubMedCrossRef
go back to reference Elsass P, Christensen SE, Jorgensen F, Mortensen EL, Vilstrup H (1984) Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta pharmacol et toxicol 54:115–119CrossRef Elsass P, Christensen SE, Jorgensen F, Mortensen EL, Vilstrup H (1984) Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta pharmacol et toxicol 54:115–119CrossRef
go back to reference Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366PubMedCrossRef Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366PubMedCrossRef
go back to reference Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139PubMedCrossRef Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139PubMedCrossRef
go back to reference Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis [Epub ahead of print]. doi:10.1007/s11011-012-9318-6 Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis [Epub ahead of print]. doi:10.​1007/​s11011-012-9318-6
go back to reference Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W (2002) Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 17(1):29–40PubMedCrossRef Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W (2002) Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 17(1):29–40PubMedCrossRef
go back to reference Randolph C (1998) The repeatable battery for the assessment of neuropsychological status (RBANS). The Psychological Corporation, San Antonio Randolph C (1998) The repeatable battery for the assessment of neuropsychological status (RBANS). The Psychological Corporation, San Antonio
go back to reference Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Internat 29(5):629–635CrossRef Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Internat 29(5):629–635CrossRef
go back to reference Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377PubMedCrossRef Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377PubMedCrossRef
go back to reference Smith JM, Misiak H (1976) Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects—a review. Psychopharmacology 47:175–182CrossRef Smith JM, Misiak H (1976) Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects—a review. Psychopharmacology 47:175–182CrossRef
go back to reference Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRef
Metadata
Title
Psychometric tests for diagnosing minimal hepatic encephalopathy
Author
Karin Weissenborn
Publication date
01-06-2013
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 2/2013
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-012-9336-4

Other articles of this Issue 2/2013

Metabolic Brain Disease 2/2013 Go to the issue